TY - JOUR
T1 - Sequential development of distinct clonal chromosome abnormalities in a patient with preleukaemia
AU - Miller, Barbara
AU - Weinstein, Howard J.
AU - Nell, Marilyn
AU - Henkle, Carol T.
AU - Dillon, Patricia L.
AU - Tantravahi, Ramana
PY - 1985/1/1
Y1 - 1985/1/1
N2 - Summary Preleukaemia has been identified as a clonal haemopathy in which progression to acute leukaemia involves conservation of the preleukaemic karyotype in the blast cells or the development of new abnormalities superimposed on the original clone. In this report, a case of childhood preleukaemia is presented in which two cytogenetically distinct clones developed over 2 years in a dysplastic marrow that was initially karyotypically normal. One clone with 47 chromosomes (47, XY, + 21), disappeared without therapy. Predominance of the cytogenetically abnormal clone, 45,XY,−12,−17,t(12;17)(p11;q11) was associated with the development of acute myelogenous leukaemia and myelofibrosis. The development of independent clonal abnormalities in the unstable preleukaemic marrow may occur more commonly than has been previously recognized. Implications of the progression of the karyotypic abnormalities are discussed.
AB - Summary Preleukaemia has been identified as a clonal haemopathy in which progression to acute leukaemia involves conservation of the preleukaemic karyotype in the blast cells or the development of new abnormalities superimposed on the original clone. In this report, a case of childhood preleukaemia is presented in which two cytogenetically distinct clones developed over 2 years in a dysplastic marrow that was initially karyotypically normal. One clone with 47 chromosomes (47, XY, + 21), disappeared without therapy. Predominance of the cytogenetically abnormal clone, 45,XY,−12,−17,t(12;17)(p11;q11) was associated with the development of acute myelogenous leukaemia and myelofibrosis. The development of independent clonal abnormalities in the unstable preleukaemic marrow may occur more commonly than has been previously recognized. Implications of the progression of the karyotypic abnormalities are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0021911548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021911548&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.1985.tb07327.x
DO - 10.1111/j.1365-2141.1985.tb07327.x
M3 - Article
C2 - 3855652
AN - SCOPUS:0021911548
SN - 0007-1048
VL - 59
SP - 411
EP - 418
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 3
ER -